Skip to main content
. Author manuscript; available in PMC: 2022 Jan 25.
Published in final edited form as: Int J Pharm. 2020 Dec 2;593:120121. doi: 10.1016/j.ijpharm.2020.120121

Figure 7.

Figure 7

SDS-PAGE analysis for ID93 presence based on existence and location of band. Analysis was completed on all inhalable vaccine candidates. SDS-PAGE analysis for a control ID93+GLA-SE formulation has been provided in the last lane for comparison. Analysis indicates that the ID93 band is present for all formulations except those containing pullulan. Relative ID93 content among different formulations cannot be determined based on band intensity as the figure shown was combined from different imaged gels.